Effectiveness of low-dose mepolizumab in refractory eosinophilic granulomatosis with polyangiitis: systemic steroid use and remission
Background/Aims This study investigated the clinical efficacy of low-dose mepolizumab (100 mg) in controlling severe eosinophilic asthma, aiming to induce eosinophilic granulomatosis with polyangiitis (EGPA) remission and reduce systemic steroid usage. Additionally, we constructed a basic frame for...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
The Korean Association of Internal Medicine
2026-01-01
|
| Reeks: | The Korean Journal of Internal Medicine |
| Onderwerpen: | |
| Online toegang: | http://kjim.org/upload/kjim-2025-130.pdf |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|